Pages that link to "Q40636449"

The following pages link to Anti-proliferative effect of the abl tyrosine kinase inhibitor STI571 on the P-glycoprotein positive K562/ADM cell line (Q40636449):

Displaying 13 items.

• Kinase-independent mechanisms of resistance of leukemia stem cells to tyrosine kinase inhibitors (Q26849792) (← links)
• Molecular mechanisms of acquired resistance to tyrosine kinase targeted therapy (Q33828409) (← links)
• Outcome of treatment of chronic myeloid leukemia with second-generation tyrosine kinase inhibitors after imatinib failure (Q35596200) (← links)
• Management of imatinib-resistant patients with chronic myeloid leukemia (Q36776423) (← links)
• The Bcr-Abl tyrosine kinase inhibitor imatinib and promising new agents against Philadelphia chromosome-positive leukemias (Q36967858) (← links)
• Interaction of nilotinib, dasatinib and bosutinib with ABCB1 and ABCG2: implications for altered anti-cancer effects and pharmacological properties (Q37447522) (← links)
• Seeking the causes and solutions to imatinib-resistance in chronic myeloid leukemia (Q37811878) (← links)
• Tyrosine kinase inhibitors as modulators of ATP binding cassette multidrug transporters: substrates, chemosensitizers or inducers of acquired multidrug resistance? (Q37853578) (← links)
• Characterization of a multidrug-resistant chronic myeloid leukemia cell line presenting multiple resistance mechanisms (Q39121828) (← links)
• The anticancer effect of cytotoxin 1 from Naja atra Cantor venom is mediated by a lysosomal cell death pathway involving lysosomal membrane permeabilization and cathepsin B release (Q39147019) (← links)
• Inhibition of PRAME expression causes cell cycle arrest and apoptosis in leukemic cells (Q39546593) (← links)
• Differentiation and drug resistance relationships in leukemia cells. (Q40497982) (← links)
• Loss of P-glycoprotein expression in hematopoietic stem cells does not improve responses to imatinib in a murine model of chronic myelogenous leukemia (Q46586986) (← links)